Azafaros has built a strong scientific platform supported by leading academic institutions and industry partners.
We are determined to advance our programs with the highest quality and efficiency and are always open to discuss new collaborations for this purpose.

For any question please contact

Patient Community

Azafaros is reaching out to the rare disease community for the benefit of the patients. We are devoted to share and learn to advance our programs in the most meaningful way.

For any question please contact


Our investor syndicate comprises leading European biotech investors with long-standing expertise in the drug development area.


BioGeneration Ventures


Schroder Adveq